Biocept, Inc.
BIOC
BIOC was delisted on the 24th of October, 2023.
15 hedge funds and large institutions have $2.87M invested in Biocept, Inc. in 2017 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 7 closing their positions.
202% more call options, than puts
Call options by funds: $175K | Put options by funds: $58K
100% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 2
9.88% less ownership
Funds ownership: 17.76% → 7.87% (-9.9%)
17% less funds holding
Funds holding: 18 → 15 (-3)
43% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 7
65% less capital invested
Capital invested by funds: $8.25M → $2.87M (-$5.38M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Creative Planning
Overland Park,
Kansas
|
+$382K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$98.9K |
| 3 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$70.7K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$56.5K |
| 5 |
US Bancorp
Minneapolis,
Minnesota
|
+$42.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AFM
Anson Funds Management
Dallas,
Texas
|
-$1.39M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$1.26M |
| 3 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$851K |
| 4 |
WA
WealthTrust Axiom
Wayne,
Pennsylvania
|
-$298K |
| 5 |
GCM
Goldman Capital Management
New York
|
-$213K |
BIOC Hedge Fund Activity: Q2 2017 in Review
15 of the 4,022 institutional investors tracked by Wall St. Rank reported a position in Biocept, Inc. (BIOC) for Q2 2017, worth a combined $2.87M — down 65% from $8.25M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of BIOC and 4 opened new positions — a net loss of 3 holders — while 2 trimmed existing stakes and 4 added.
The largest buyer was Creative Planning, opening a new position worth an estimated $382K. The largest seller was Anson Funds Management, exiting entirely with an estimated $1.39M sold.
- 15 institutional investors held Biocept, Inc. (BIOC) as of Q2 2017, down from 18 in Q1 2017.
- Funds reported $2.87M of Biocept, Inc. stock for Q2 2017, down 65% quarter-over-quarter.
- 4 funds opened new Biocept, Inc. positions in Q2 2017 and 7 closed out, a net change of -3 holders.
- The largest Biocept, Inc. buyer in Q2 2017 was Creative Planning, an estimated $382K added.
- The largest Biocept, Inc. seller in Q2 2017 was Anson Funds Management, an estimated $1.39M sold.
Based on aggregated 13F filings for Q2 2017.